openPR Logo
Press release

Hematological Disorders - Pipeline Insight and Therapeutic Assessment Reviewed in 2017

09-04-2017 04:15 PM CET | Health & Medicine

Press release from: Market Research Hub - Pharmaceutical Industry

Market Research Hub

Market Research Hub

Market Research Hub (MRH) has recently added a new report on “hematological disorders therapy” area encompasses non-malignant disorders of the blood such as anemia, sickle cell disease, neutropenia and hemophilia. These diseases can be grouped into the three categories- red blood cell disorders, bleeding disorders and immune cell disorders - of which red blood cell disorders are characterized by significant unmet need related to few effective treatment options and poor prognosis. As such, they are the primary focus of the report.

Request For Free Sample - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1313840

Historically, the hematological disorders therapy area has suffered from a lack of funding for research, which has contributed to the level of unmet need, although there have been instances in which funding for an indication has resulted in a strong return on investment. A notable example is the approval of Soliris in 2007, which is used to treat the orphan disease paroxysmal nocturnal hemoglobinuria. Soliris is one of only two marketed treatment options for PNH and is forecast to generate annual revenue of over $3 billion by the end of 2017, rising to $5.5 billion in 2023.

The report assesses first-in-class innovation in the hematological disorders pipeline, highlighting key trends in the pipeline, and emerging treatment classes. There are 92 first-in-class products in development in this therapy area; which account for 28% of products in the overall pipeline for which there is a disclosed molecular target, and act upon 71 unique individual molecular targets.

These first-in-class targets in the pipeline are numerous and varied, with many of them having been shown to be promising in early stage studies. Immune components are the most common, accounting for a total of 21 first-in-class developmental programs, closely followed by DNA regulators. These target categories combined account for the majority of red blood cell disorder pipeline therapies, although iron regulator programs alone also appear frequently.

Browse Full Report With TOC - http://www.marketresearchhub.com/report/frontier-pharma-hematological-disorders-iron-regulators-and-immune-response-targeted-programs-within-anemias-and-other-red-blood-cell-disorders-hold-potential-to-transform-therapy-area-with-significant-unmet-need-report.html

Scope

- With 488 products in active development, the pipeline for hematological disorders is modestly sized. Does current pipeline innovation hold the potential to affect the future hematological disorders market?
- There are 92 first-in-class products in the hematological disorders pipeline, which act on a novel molecular target which is not present in an approved product across any indication the pharmaceutical industry. Which of these hold the greatest potential to improve future disease treatment with regard to their molecular target?

- Analysis of the history of strategic consolidations revealed a modest level of deal activity in recent years and a large number of first-in-class products not yet involved in any deals. How do deal frequency and value compare between target families and molecule types, and which first-in-class programs which have not yet been involved in a licensing or co-development deal appear to be particularly promising?

Reasons to buy

- Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis and prognosis, and the treatment options available.
- Visualize the composition of the hematological disorders market in terms of dominant molecule types and targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
- Analyze the hematological disorders pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating hematological disorders to overcome the overwhelming level of unmet need.
- Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.

- Identify commercial opportunities in the hematological disorders deals landscape by analyzing trends in licensing and co-development deals and analyzing a curated list of hematological disorder therapies that have not yet been involved in deals, and may offer potential investment opportunities.

Make an Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1313840

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:

90 State Street,
Albany, NY 12207,
United States
Toll Free : 800-998-4852 (US-Canada)
Email : press@marketresearchhub.com
Website : http://www.marketresearchhub.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hematological Disorders - Pipeline Insight and Therapeutic Assessment Reviewed in 2017 here

News-ID: 697550 • Views: 260

More Releases from Market Research Hub - Pharmaceutical Industry

Global Enthesopathy Treatment Market Analysis by Type, Application, Top Key Play …
The global market status for Enthesopathy Treatment is precisely examined through a smart research report added to the broad database managed by Market Research Hub (MRH). This study is titled “Global Enthesopathy Treatment Market Size, Status and Forecast 2019-2025”, which tends to deliver in-depth knowledge associated to the Enthesopathy Treatment market for the present and forecasted period until 2025. Furthermore, the report examines the target market based on market size,
Global BioImaging Technologies Market Status, Growth Opportunity, Scope, Key Pla …
The market for BioImaging Technologies is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global BioImaging Technologies Market Size, Status and Forecast 2019-2025” which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions. Furthermore,
Global Drugs and Diagnostics for Hematological Disorders Market Report Overview …
Market Research Hub (MRH) has actively included a new research study titled “Global Drugs and Diagnostics for Hematological Disorders Market Size, Status and Forecast 2019-2025” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period
Global Biosimilar Testing and Development Services Market Report Overview 2019-2 …
Market Research Hub (MRH) has actively included a new research study titled “Global Biosimilar Testing and Development Services Market Size, Status and Forecast 2019-2025” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until

All 5 Releases


More Releases for MRH

Global Dystrophin Pharmaceuticals Industry Research Report - MRH
A fresh report has been added to the wide database of Market Research Hub (MRH). The research study is titled “Global Dystrophin Market Research Report” which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview. The report anticipates that the sector for Pharmaceutical would rise at a positive CAGR during the period 2017-2022. Request For Free Sample -
Global VOD In Hospitality Industry Trends and Forecast Report- MRH Report (2017) …
MRH announced a 'Medical Equipment' related topic "VOD In Hospitality Report by Material, Application, and Geography-Global Forecast to 2021" is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe, and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Request For Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1054148 The report firstly introduced the VOD In Hospitality basics:
Global Neuromodulation Market Research Report 2016 - MRH
This report of MRH studies Neuromodulation in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacture. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=850706 Area Covering Medtronic, Inc. (U.S.) Boston Scientific Corporation (U.S.) St. Jude Medical, Inc. (U.S.) Synapse Biomedical, Inc. (U.S.) Nevro Corporation (U.S.) Neurosigma, Inc. (U.S.) Neuropace, Inc. (U.S.). Neuronetics, Inc. (U.S.) Cyberonics, Inc. (U.S.) BioControl Medical (Israel) Market Segment by Regions,
Smokeless Tobacco in Germany, 2017 Report : MRH
Although Germany is the largest market for cigarettes in Western Europe it has one of the smallest smokeless tobacco markets. Smokeless tobacco currently accounts for only 1.2% of the whole tobacco market as consumers prefer traditional cigarettes and cigars. Nevertheless, the market is well established in Germany due to its proximity to Scandavian countries to the north but is not popular among young adults. In addition to this, new EU
Global Beef Market Research Report 2017 - MRH
MRH Report: The "Global Beef Market" Research Report 2017 is a professional and in-depth study on the current state of the Beef market. Annual estimates and forecasts are provided for the period 2016 through 2021. Also, a six-year historic analysis is provided for these markets. The global market for Beef is expected to reach about 232243 Million USD by 2021 from 237639 Million USD in 2016, registering a Compounded Annual
Global Billiards and Snooker Equipment Market Research Report 2017 - MRH
Market Research Hub announced the report on the retailing topic "Billiards and Snooker Equipment Market Research". Request a Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1037675 Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Billiards and Snooker Equipment in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Global Billiards and Snooker Equipment market competition by top manufacturers, with production, price, revenue (value)